Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page
- Check7 days agoChange DetectedA site revision/version indicator on the record history page was updated from v3.5.2 to v3.5.3, reflecting a platform change rather than a change to the clinical trial record contents.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedA new Revision: v3.4.3 is added to the history and Revision: v3.4.2 is removed.SummaryDifference0.1%

- Check78 days agoChange Detected- The latest revision is v3.4.2, replacing v3.4.1 in the history. This appears to be a minor maintenance update with no change to study data or content.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page history.SummaryDifference0.1%

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.